Harsha Ganesan

11 papers receiving 672 citations

Hit Papers

COVID-19: A promising cure for the global panic20202026202220242020100200300400

Peers

Harsha Ganesan
Comparison fields: 5 of 134
  • Infectious Diseases 253
  • Molecular Biology 140
  • Complementary and alternative medicine 108
  • Pharmacology 65
  • Neurology 55
Replace Kamarajan Rajagopalan with:
Kamarajan Rajagopalan India
Mohana Devi Subramaniam India
Kaavya Jayaramayya India
Anila Venugopal India
Manoela Marques Ortega Brazil
Bin Peng China
Chengzhi Wang China
Siukan Law Hong Kong
Ge Li China
Weijing Wu China
Harsha Ganesan relative to Kamarajan Rajagopalan India Kamarajan Rajagopalan's profile →
Citations per field
00.5×1.5×
Kamarajan Rajagopalan · 1×
Citations per year

Countries citing papers authored by Harsha Ganesan

Since Specialization
Citations

This map shows the geographic impact of Harsha Ganesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harsha Ganesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harsha Ganesan more than expected).

Fields of papers citing papers by Harsha Ganesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harsha Ganesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harsha Ganesan. The network helps show where Harsha Ganesan may publish in the future.

Co-authorship network of co-authors of Harsha Ganesan

This figure shows the co-authorship network connecting the top 25 collaborators of Harsha Ganesan. A scholar is included among the top collaborators of Harsha Ganesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harsha Ganesan. Harsha Ganesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 4
3 6
4 9
5 5
6 50
7 19
8 4
9 5
10 87
11
COVID-19: A promising cure for the global panicbreakdown →
449
12 54

About Harsha Ganesan

Harsha Ganesan is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Pathology and Forensic Medicine, having authored 12 papers that have together received 692 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (3 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Infectious Diseases (253 citations), Complementary and alternative medicine (108 citations) and Modeling and Simulation (41 citations). Harsha Ganesan has collaborated with scholars based in India, United Kingdom and Sweden. Frequent co-authors include Anila Venugopal, Balachandar Vellingiri, Ssang‐Goo Cho, Mahalaxmi Iyer, Pattanathu Rahman, Arul Narayanasamy, Mohana Devi Subramaniam, Kamarajan Rajagopalan, Dhivya Venkatesan and Kaavya Jayaramayya. Their work appears in journals such as The Science of The Total Environment, International Journal of Molecular Sciences and Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026